Literature DB >> 29959401

Exosomal PD-L1 harbors active defense function to suppress T cell killing of breast cancer cells and promote tumor growth.

Yi Yang1, Chia-Wei Li1, Li-Chuan Chan1,2, Yongkun Wei1, Jung-Mao Hsu1, Weiya Xia1, Jong-Ho Cha1, Junwei Hou1, Jennifer L Hsu1, Linlin Sun1,3, Mien-Chie Hung4,5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29959401      PMCID： PMC6082826          DOI： 10.1038/s41422-018-0060-4

Source DB:  PubMed          Journal:  Cell Res        ISSN： 1001-0602            Impact factor:   25.617


× No keyword cloud information.
  14 in total

Review 1.  Microenvironmental regulation of tumor progression and metastasis.

Authors:  Daniela F Quail; Johanna A Joyce
Journal:  Nat Med       Date:  2013-11       Impact factor: 53.440

2.  PD-L2:PD-1 involvement in T cell proliferation, cytokine production, and integrin-mediated adhesion.

Authors:  Paul A Saunders; Vana R Hendrycks; William A Lidinsky; Melody L Woods
Journal:  Eur J Immunol       Date:  2005-12       Impact factor: 5.532

Review 3.  Exosome mediated communication within the tumor microenvironment.

Authors:  Lara Milane; Amit Singh; George Mattheolabakis; Megha Suresh; Mansoor M Amiji
Journal:  J Control Release       Date:  2015-07-02       Impact factor: 9.776

4.  Exosomes mediate the cell-to-cell transmission of IFN-α-induced antiviral activity.

Authors:  Jianhua Li; Kuancheng Liu; Yang Liu; Yan Xu; Fei Zhang; Huijuan Yang; Jiangxia Liu; Tingting Pan; Jieliang Chen; Min Wu; Xiaohui Zhou; Zhenghong Yuan
Journal:  Nat Immunol       Date:  2013-07-07       Impact factor: 25.606

5.  Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity.

Authors:  Tyler J Curiel; Shuang Wei; Haidong Dong; Xavier Alvarez; Pui Cheng; Peter Mottram; Roman Krzysiek; Keith L Knutson; Ben Daniel; Maria Carla Zimmermann; Odile David; Matthew Burow; Alan Gordon; Nina Dhurandhar; Leann Myers; Ruth Berggren; Akseli Hemminki; Ronald D Alvarez; Dominique Emilie; David T Curiel; Lieping Chen; Weiping Zou
Journal:  Nat Med       Date:  2003-04-21       Impact factor: 53.440

6.  Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET.

Authors:  Héctor Peinado; Maša Alečković; Simon Lavotshkin; Irina Matei; Bruno Costa-Silva; Gema Moreno-Bueno; Marta Hergueta-Redondo; Caitlin Williams; Guillermo García-Santos; Cyrus Ghajar; Ayuko Nitadori-Hoshino; Caitlin Hoffman; Karen Badal; Benjamin A Garcia; Margaret K Callahan; Jianda Yuan; Vilma R Martins; Johan Skog; Rosandra N Kaplan; Mary S Brady; Jedd D Wolchok; Paul B Chapman; Yibin Kang; Jacqueline Bromberg; David Lyden
Journal:  Nat Med       Date:  2012-06       Impact factor: 53.440

Review 7.  T cell activation.

Authors:  Jennifer E Smith-Garvin; Gary A Koretzky; Martha S Jordan
Journal:  Annu Rev Immunol       Date:  2009       Impact factor: 28.527

Review 8.  PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations.

Authors:  Weiping Zou; Jedd D Wolchok; Lieping Chen
Journal:  Sci Transl Med       Date:  2016-03-02       Impact factor: 17.956

9.  Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade-mediated tumor regression.

Authors:  Heng Lin; Shuang Wei; Elaine M Hurt; Michael D Green; Lili Zhao; Linda Vatan; Wojciech Szeliga; Ronald Herbst; Paul W Harms; Leslie A Fecher; Pankaj Vats; Arul M Chinnaiyan; Christopher D Lao; Theodore S Lawrence; Max Wicha; Junzo Hamanishi; Masaki Mandai; Ilona Kryczek; Weiping Zou
Journal:  J Clin Invest       Date:  2018-01-16       Impact factor: 14.808

10.  Tumour and host cell PD-L1 is required to mediate suppression of anti-tumour immunity in mice.

Authors:  Janet Lau; Jeanne Cheung; Armando Navarro; Steve Lianoglou; Benjamin Haley; Klara Totpal; Laura Sanders; Hartmut Koeppen; Patrick Caplazi; Jacqueline McBride; Henry Chiu; Rebecca Hong; Jane Grogan; Vincent Javinal; Robert Yauch; Bryan Irving; Marcia Belvin; Ira Mellman; Jeong M Kim; Maike Schmidt
Journal:  Nat Commun       Date:  2017-02-21       Impact factor: 14.919
View more
  126 in total

Review 1.  Extracellular vesicles as cancer liquid biopsies: from discovery, validation, to clinical application.

Authors:  Zhen Zhao; Jia Fan; Yen-Michael S Hsu; Christopher J Lyon; Bo Ning; Tony Y Hu
Journal:  Lab Chip       Date:  2019-03-27       Impact factor: 6.799

2.  Clinical significance of circulating exosomal PD-L1 and soluble PD-L1 in extranodal NK/T-cell lymphoma, nasal-type.

Authors:  Ji-Wei Li; Ping Wei; Ye Guo; Di Shi; Bao-Hua Yu; Yi-Fan Su; Xiao-Qiu Li; Xiao-Yan Zhou
Journal:  Am J Cancer Res       Date:  2020-12-01       Impact factor: 6.166

Review 3.  Mechanisms Controlling PD-L1 Expression in Cancer.

Authors:  Jong-Ho Cha; Li-Chuan Chan; Chia-Wei Li; Jennifer L Hsu; Mien-Chie Hung
Journal:  Mol Cell       Date:  2019-10-24       Impact factor: 17.970

Review 4.  Immune Escape Mediated by Exosomal PD-L1 in Cancer.

Authors:  Sean E Lawler; Michal O Nowicki; Franz L Ricklefs; E Antonio Chiocca
Journal:  Adv Biosyst       Date:  2020-05-07

Review 5.  Exosomes in cancer development, metastasis, and immunity.

Authors:  Lin Zhang; Dihua Yu
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2019-04-30       Impact factor: 10.680

6.  The stabilization of PD-L1 by the endoplasmic reticulum stress protein GRP78 in triple-negative breast cancer.

Authors:  Cheng-Wei Chou; Ri-Yao Yang; Li-Chuan Chan; Ching-Fei Li; Linlin Sun; Heng-Huan Lee; Pei-Chih Lee; Yuh-Pyng Sher; Haoqiang Ying; Mien-Chie Hung
Journal:  Am J Cancer Res       Date:  2020-08-01       Impact factor: 6.166

Review 7.  Multimodal detection of PD-L1: reasonable biomarkers for immune checkpoint inhibitor.

Authors:  Qiao Yang; Zihan Xu; Linpeng Zheng; Luping Zhang; Qiai You; Jianguo Sun
Journal:  Am J Cancer Res       Date:  2018-09-01       Impact factor: 6.166

Review 8.  Exosomal PD-L1: Roles in Tumor Progression and Immunotherapy.

Authors:  Samantha M Morrissey; Jun Yan
Journal:  Trends Cancer       Date:  2020-03-29

Review 9.  Liquid Biopsies to Evaluate Immunogenicity of Gynecological/Breast Tumors: On the Way to Blood-Based Biomarkers for Immunotherapies.

Authors:  Corinna Keup; Rainer Kimmig; Sabine Kasimir-Bauer
Journal:  Breast Care (Basel)       Date:  2020-10-07       Impact factor: 2.860

Review 10.  Emerging role of tumor cell plasticity in modifying therapeutic response.

Authors:  Siyuan Qin; Jingwen Jiang; Yi Lu; Edouard C Nice; Canhua Huang; Jian Zhang; Weifeng He
Journal:  Signal Transduct Target Ther       Date:  2020-10-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.